Keywords: اینترلوکین; Alcohol; High-Fat Diet; Fatty Liver; Reactive Oxygen Species; Inflammation; ALT; alanine aminotransferase; AST; aspartate aminotransferase; cDNA; complementary DNA; Csf; colony-stimulating factor gene; CXCL1; chemokine (C-X-C motif) ligand 1; FBS; fetal b
مقالات ISI اینترلوکین (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: اینترلوکین; Colon Cancer; Marker; Microbiome; Pathogen; CDARS; Clinical Data Analysis and Reporting System; CI; confidence interval; CRC; colorectal cancer; HR; hazard ratio; IL; interleukin;
Keywords: اینترلوکین; ALP; alkaline phosphatase; BMPs; bone morphogenetic proteins; C/EBPÃ; CCAAT/enhancer binding protein beta; CIA; collagen II induced arthritis; CTD; C-terminal domain; Cx43; connexin43; Cxs; connexins; DMOADs; disease-modifying osteoarthritis drugs; ECM;
Keywords: اینترلوکین; BDNF; brain-derived neurotrophic factor; CON; control diet; EPM; elevated plus maze; FST; forced swim test; GR; glucocorticoid receptor; HFD; high-fat diet; HPA; hypothalamic-pituitaryadrenal; IGF; insulin-like growth factor; IL; interleukin; KAT; kynur
Keywords: اینترلوکین; 1-MT; 1-methyltryptophan; 3-HK; 3-hydroxykynurenine; 5-HT; serotonin; 5-HTP; 5-hydroxy-l-tryptophan; 5-HIAA; 5-hydroxyindoleatic acid; ACTH; adrenocorticotrophic hormone; AADC; aromatic l-amino acid descarboxylase; AA-NAT; aralkylamine N-acetyltransferase
Keywords: اینترلوکین; AA; Arachidonic acid; ALX/FPR2; Lipoxin A4/formyl peptide receptor 2; AnxA1; Annexin A1; ASA; Acetylsalicylic acid; AT; Aspirin-triggered; BHR; Bronchial hyper-reactivity; COX; Cyclooxygenase; DHA; Docosahexaenoic acid; Eos; Eosinophils; EPA; Eicosapentae
Keywords: اینترلوکین; RT; radiation therapy; IFN-γ; interferon-γ; TLR; toll-like receptor; STAT; signal transducer and activator of transcription; NF-κB; nuclear factor-κB; CXCLs; C-X-C motif ligands; CCLs; C-C motif ligands; iNOS; inducible nitric oxide synthase; IL; inte
Keywords: اینترلوکین; Immune Response; Kras; PDAC; Tumorigenesis; ADM; Acinar-ductal metaplasia; AKT; protein kinase B; ERK; extracellular signal-regulated kinase; ESC; embryonic stem cell; GFP; green fluorescent protein; IL; interleukin; IL17R; interleukin 17 receptor; JNK;
Keywords: اینترلوکین; P; prednisone; RIF; repeated embryo implantation failure; IL; interleukin; uNK cells; uterine natural killer cells; Corticoids; IVF/ICSI; Uterine receptivity; Endometrium; Implantation failures;
Keywords: اینترلوکین; Intestine; Hedgehog; Stroma; Inflammation; CXCL12; α-SMA; α smooth muscle actin; CXCL; C-X-C motif chemokine ligand; CXCR; C-X-C motif chemokine receptor; DMEM; Dulbecco's modified Eagle medium; DSS; dextran sodium sulfate; FCS; fetal calf serum; Gli; g
Keywords: اینترلوکین; AD; Alzheimer's disease; ARA; arachidonic acid; CD; cluster of differentiation; iPLA2; calcium independent phospholipase A2; cPLA2; cytosolic phospholipase A2; DHA; docosahexaenoic acid; EPA; eicosapentaenoic acid; HDHA; hydroxy DHA; HETE; hydroxyeicosa
Keywords: اینترلوکین; ACE; angiotensin converting enzyme; AO; acridine orange; BAD; Bcl-2-associated death promoter; BAX; BCL2-associated X protein; B cells; B lymphocytes; Bcl-2; B-cell lymphoma 2; CCL18; chemokine (CC motif) ligand 18; CD; cluster of differentiation; CDK2; c
Keywords: اینترلوکین; STY; Salmonella Typhi; STM; Salmonella Typhimurium; M cells; Microfold cells; CFU; colony forming units; LB; Luria Burtoni broth; DMEM; Dulbecco's Modified Eagle Medium; PBS; phosphate buffered saline; DTT; dithiothreitol; EDTA; ethylenediaminetetraacetic
Keywords: اینترلوکین; aCL; anticardiolipin; ADP; adenosine diphosphate; APOH; apolipoprotein H; APS; antiphospholipid syndrome; β2GPI; β2-glycoprotein I; DVT; deep vein thrombosis; FDR; false discovery rate; GO; gene ontology; IL; interleukin; IRAK 1; interleukin-1 receptor-
Keywords: اینترلوکین; 6MWT; 6-Minute Walk Test; AACE; American Association of Clinical Endocrinologists; ACE; American College of Endocrinology; ADT; androgen deprivation therapy; BMI; body mass index; BRS; baroreflex sensitivity; CAC; coronary artery calcium; CAD; coronary ar
Keywords: اینترلوکین; NASH; NAFLD; HCV; HBV; ROS; AFLD; alcoholic fatty liver disease; AMPK; adenosine monophosate-activated protein kinase; ASH; alcoholic steatohepatitis; ASK1; mitogen-activated protein kinase kinase kinase 5; ATP; adenosine triphosphate; CoA; coenzyme A;
Keywords: اینترلوکین; Microbe; Stomach; Pathogen; Cancer; ANOVA; analysis of variance; cagPAI; cag pathogenicity island; IL; interleukin; MTases; methyltransferases; OMP; outer membrane protein; PCR; polymerase chain reaction; R-M; Restriction-Modification; SMRT sequencing; si
Keywords: اینترلوکین; AMPK; adenosine 5â²-monophosphate (AMP)-activated protein kinase; ANGPTL4; angiopoietin-like protein 4; AX; arabinoxylan; CAZymes; carbohydrate active enzymes; CBMs; carbohydrate-binding modules; CVD; cerebrobascular disease; ERs; estrogen receptors; IL;
Keywords: اینترلوکین; 2-AG; 2-arachidonoylglycerol; Aβ; β-amyloid; GABA; γ-amino butyric acid; AD; Alzheimer's diseases; ALS; amyotrophic lateral sclerosis; AEA; anandamide; EAE; autoimmune encephalomyelitis; BBB; blood brain barrier; CDB; cannabidiol; CB; cannabinoid rec
Keywords: اینترلوکین; Enteroids; Organoids; Infections; Microbiome; Host-Microbial Interactions; HBGA; histo-blood group antigen; IFN; interferon; IL; interleukin; 3D; three-dimensional;
Keywords: اینترلوکین; AD; Alzheimer's disease; AGEs; advanced glycation end products; BBB; blood-brain barrier; BDNF; brain-derived nerve growth factor; CML; carboxymethyllysine; CMRg; cerebral metabolic rate of glucose; DAMPs; damage-associated molecular patterns; GLUT; gluco
Keywords: اینترلوکین; FK228 (PubChem CID: 5352062); PXD101 (PubChem CID: 6918638); SAHA (PubChem CID: 5311); LBH-589 (PubChem CID: 6918837); tubacin (PubChem CID: 6675804); tubastatin A (PubChem CID: 49850262); ACY-1215 (PubChem CID: 53340666); ACY-241 (PubChem CID: 53340426);
Keywords: اینترلوکین; OA; osteoarthritis; MMP; matrix metalloproteinase; TNF-α; tumor necrosis factor-α; IL-6; interleukin-6; PBS; phosphate-buffered saline; MIA; monosodium iodoacetate; TIMP; tissue inhibitor of metalloproteinase; IL; interleukin; CTX-II; C-terminal crossli
Keywords: اینترلوکین; SONFH; Steroid (glucocorticoid)-induced osteonecrosis of the femoral head; NONFH; nontraumatic osteonecrosis of the femoral head; GC; glucocorticoid; HSD1; hydroxysteroid dehydrogenase 1; PPARγ; peroxisome proliferator-activated receptor γ; LRP5; lipopr
Keywords: اینترلوکین; Epithelial Barrier; Serine Proteases; Gut Microbiota; Inflammatory Bowel Diseases; ABx; antibiotics; AEBSF; 4-(2-aminoethyl) benzenesulfonyl fluoride hydrochloride; cecal-sup; cecal-supernatants; ctr; control; DSS; dextran sulfate sodium; GF; germ-free; I
Keywords: اینترلوکین; IL; interleukin; SLE; systemic lupus erythematosus; SNPs; single nucleotide polymorphisms; IFN; Interferon; TGF; transforming growth factor; BAFF; B cells-activating factor; GWAS; genome-wide association studies; ACR; American College of Rheumatology; HWE
Keywords: اینترلوکین; NHANES; Periodontal diseases; Tooth loss; Inflammation; Diet; Nutrition; (BMI); Body-mass Index; (CRP); C-reactive protein; (DII); Dietary Inflammatory Index; (IL); Interleukin; (NHANES); National Health and Nutrition Examination Surveys; (PIR); Poverty-i
Keywords: اینترلوکین; HO; Heterotopic ossification; IL; interleukin; MCP; Monocyte chemoattractant protein; TBI; Traumatic brain injury; BMP; Bone morphogenetic proteins; MSC; Mesenchymal stem cells; CXCR4; C-X-C chemokine receptor type 4; CD; Cluster of differentiation; VEGF;
Keywords: اینترلوکین; ARID; Age Related Immune Differences; CD40L; CD40 ligand; CTLA-4; cytotoxic T lymphocyte antigen-4; IL; interleukin; Lag3; lymphocyte activation gene 3; MDSC; myeloid derived suppressor cell; MHC; major histocompatibility complex; mTOR; mammalian target o
Keywords: اینترلوکین; ALP; Alkaline phosphatase; ALT; Alanine aminotransferase; AST; Aspartate aminotransferase; γGT; Gamma glutamyl transferase; HE; Hepatic encephalopathy; hs-CRP; high sensitivity C-reactive protein; iNOS; Inducible nitric oxide synthase; IL; Interleukin; I
Keywords: اینترلوکین; Nervous system; Neurotransmitters; Neuropeptides; Neuro-immune interaction; Cancer-associated immune cells; Ach; acetylcholine; beta2-AR; beta2-adrenergic receptor; CAF; cancer associated fibroblasts; CNS; central nervous system; cAMP; cyclic adenosine mo
Keywords: اینترلوکین; Der p; Dermatophagoides pteronyssinus; Dex; dexamethasone; ELISA; enzyme-linked immunosorbent assay; EMSA; electrophoretic mobility shift assay; FBS; foetal bovine serum; GMCSF; granulocyte-macrophage colony-stimulating factor; GMP; good manufacturing pra
Keywords: اینترلوکین; 5-LOX; 5-lipoxygenase; AA; arachidonic acid; ANOVA; analysis of variance; AP-1; activating protein-1; CGEN; Brazilian Genetic Heritage Management Council; CIOMS; Council of International Organizations of Medical Sciences; CONCEA; National Council for the
Keywords: اینترلوکین; CLSM; Confocal laser scanning microscope; GM-CSF; Granulocyte Macrophage Colony Stimulating Factor; LPS; Lipopolysaccharide; IFN-γ; Interferon γ; IL; Interleukin; TNF-α; Tumour Necrosis Factor α; MND; Motor Neuron Disease; CSF; Cerebrospinal fluid; Ne
Keywords: اینترلوکین; Ost; Osthole; RV; right ventricle; MCT; monocrotaline; RVHI; right ventricular hypertrophy index; LV + SEP; left ventricle plus septum; HE; Hematoxylin-eosin; TUNEL; TdT-mediated dUTP nick end labeling; Bcl-2; B cell lymphoma-2; Bax; Bcl-2 associated X pr
Keywords: اینترلوکین; AHE; Acute Hepatic Encephalopathy; ALF; Acute Liver Failure; CHE; Chronic Hepatic Encephalopathy; CNS; Central Nervous System; CSF; Cerebrospinal Fluid; ECs; Endothelial Cells; HE; Hepatic Encephalopathy; IL; Interleukin; LPS; Lipopolysaccharide; MAPKs; M
Keywords: اینترلوکین; 5-FU; 5-fluoro-uracil; AAV; adeno-associated virus; ADAM; ADAM metallopeptidase domain; ADCC; antibody-dependent cell-mediated cytotoxicity; CCL; chemokine (C-C motif) ligand; CD; cluster of differentiation; CTLA-4; cytotoxic T-lymphocyte-associated ant
Keywords: اینترلوکین; 5FU; 5-fluorouracil; 95%CI; 95% confidence interval; AA; amino acid; AFP; alpha fetoprotein; AML; actue myeloid leukemia; Ang2; angiopoietin 2; ATP; adenosine triphosphate; BCLC; Barcelona-Clinic Liver Cancer classification; BSC; best supportive care; CAP
Keywords: اینترلوکین; AP; apical periodontitis; hPDLFs; human periodontal ligament fibroblasts; IL; Interleukin; MCP-1; Monocyte chemoattractant protein-1; P. gingivalis; Porphyromonas gingivalis; AIM2; the absent in Melanoma 2; TNF-α; tumor necrosis factor-α; SD; Sprague-Da
Keywords: اینترلوکین; Aqueous humor dynamics; Conventional outflow; Glaucoma; Intraocular pressure; Ocular hypertension; Dulbecco's modified Eagle's medium; DMEM; Dimethyl sulfoxide; DMSO; Fetal bovine serum; FBS; Ethylenediaminetetraacetic acid; EDTA; Fibroblast growth factor
Keywords: اینترلوکین; DRIAs; daidzein-rich isoflavone aglycones; Iso-40; isoflavone40; OESCs; ovarian endometrioma stromal cells; NESCs; normal endometrium stromal cells; IL; interleukin; ER; estrogen receptor; Aglycone isoflavone; Endometriosis; Estrogen receptor β; Nuclear
Keywords: اینترلوکین; AMD; Age-related macular degeneration; ARPE-19; Adult retinal pigment epithelium cell line; ATP; Adenosine tri-phosphate; BRB; Blood retinal barrier; CBA; Cytometric bead array; DR; Diabetic retinopathy; GLUT-1; Glucose transporter-1; IL; Interleukin; MCP
Keywords: اینترلوکین; cfDNA; circulating cell-free DNA; CIC; circulating immune cells; DMARDs; disease-modifying disease drugs; ExV; extracellular vesicles; FLS; fibroblast-like synoviocytes; IFN; interferon; IL; interleukin; NSAIDs; nonsteroidal anti-inflammatory drugs; RA; r
Keywords: اینترلوکین; Symptomatic Uncomplicated Diverticular Disease; Painful Diverticular Disease; Symptomatic Diverticulosis; Irritable Bowel Syndrome; CI; confidence interval; IL; interleukin; mRNA; messenger RNA; OR; odds ratio; SUDD; symptomatic uncomplicated diverticular
Keywords: اینترلوکین; AI; adaptation index; BCF; beta-cell function fasting; DI; disposition index; FFA; free fatty acids; HbA1c; hemoglobin A1c; HCL; hepatocellular lipid content; HMW; high molecular weight; hsCRP; high-sensitivity C-reactive protein; IGI; insulinogenic index
Keywords: اینترلوکین; HH; hypobaric hypoxia; GFAP; glial fibrillary acidic protein; IBA-1; ionized calcium-binding adaptor molecule 1; M-PLP; myelin proteolipid protein; CA; Cornu Ammonis in hippocampus; DG; dentate gyrus in hippocampus; IL; Interleukin; TNF-α; tumor necrosis
Keywords: اینترلوکین; ED; emergency department; ICU; intensive care unit; SOFA; sequential organ failure assessment; SIRS; systemic inflammatory response syndrome; CISS; Critical Illness and Shock Study; MEDS; mortality in emergency department sepsis; CCI; Charlson comorbidity
Keywords: اینترلوکین; G-CSF; Granulocyte colony stimulating factor; HAT; Histone acetyl transferase; HDAC; Histone deacetylase; IGF; Insulin-like growth factor; IL; Interleukin; IRF; Interferon responsive factor; LDL; Low density lipoprotein; LSD; Lysine specific demethylase;
Keywords: اینترلوکین; Acute kidney injury; Cell adhesion molecules; Cytokines; Endothelial activation; Endotoxin; Human endotoxemia model; Lipopolysaccharide; LPS; AKI; acute kidney injury; αGST; alpha-gluthatione S-transferase; B2MG; beta2-microglobulin; CI; confidence inter
Keywords: اینترلوکین; Cancer; Phytochemical; Radiotherapy; Radioprotection; Side effects; AP-1; activator protein-1; Bax; Bcl-2-associated X protein; Bcl-2; B-cell lymphoma 2; CAPE; caffeic acid phenylethylester; CAT; chloramphenicol acetyltransferase; CBMN; cytokinesis block